Sax Wealth Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$313K Buy
12,998
+1,446
+13% +$35.8K 0.01% 562
2026
Q2
$292K Buy
11,552
+1,174
+11% +$29.6K 0.01% 450
2026
Q1
$265K Hold
10,378
– – 0.01% 416
2025
Q4
$265K Sell
10,378
-615
-6% -$15.7K 0.01% 425
2025
Q3
$282K Buy
+10,993
New +$279K 0.02% 360

Other funds holding IBDX

Sax Wealth Advisors's IBDX Position: Q3 2026 in Review

Sax Wealth Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 13% in Q3 2026, buying an estimated $35.8K and bringing the position to 12,998 shares worth $313K. The position accounts for 0.01% of the portfolio, ranked #562.

Sax Wealth Advisors first reported a position in IBDX in Q3 2025 and has held it in 5 quarters since. 22 funds tracked by Wall St. Rank hold IBDX as of Q3 2026.

  • Sax Wealth Advisors held 12,998 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $313K as of Q3 2026.
  • Sax Wealth Advisors bought 1,446 iShares iBonds Dec 2032 Term Corporate ETF shares in Q3 2026, an estimated $35.8K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.01% of Sax Wealth Advisors's portfolio in Q3 2026, its #562 holding.
  • Sax Wealth Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and has held it in 5 quarters since.
  • 22 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q3 2026.

Based on Sax Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.